The 340B Drug Pricing Program (340B program) is a federal drug discount program that requires drug manufacturers participating in the Medicaid drug rebate program to provide outpatient drugs to ...
Americans assume hospitals are in the business of keeping us healthy, not of buying drugs inexpensively and then reselling ...
Despite the rancor, there are many bipartisan opportunities for the divided 118 th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug ...
Changes to registration requirements for the offsite clinics of 340B-eligible hospitals represent the latest clash between providers, regulators and drugmakers amid the program’s exponential growth.
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
Regulators on Thursday finalized a flurry of rules with sweeping implications for U.S. providers, including Medicare reimbursement rates for hospital outpatient sites and doctor’s offices and a ...
The state House has an opportunity to demonstrate real leadership by insisting on accountability and shaping thoughtful policy that truly serves Michigan citizens.
In 1992, Congress established the 340B Program, which requires drug manufacturers, as a condition of participation in Medicare and Medicaid, to sell their drugs to 340B covered entities, such as ...
AbbVie group companies have sought to block a state law (HB 728) requiring it to provide the discounts to contract pharmacies ...
One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback